W

The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

金融
分享到
The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.

The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

Source：MarketWatch

友情提醒：请广大读者理性看待市场信息，切实提高风险意识。站内所有内容仅系市场信息或相关方观点，不构成任何形式投资建议。

延伸阅读

This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval

Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect laterstage cancers. Source：MarketWatch

HSBC addresses the concerns that are gripping the stock market — and dismisses most of them

Strategists at the bank recommend leaning into technology stocks, especially in the U.S. and Asia, and European banks. Source：MarketWatch

EU watchdogs warn quantum computers could pick crypto’s locks

EU supervisors warn quantum computing could weaken blockchain security as Bitcoin developers weigh a draft migration plan and Ethereum targets 2029.…

What the Trump-Xi meeting could do to strengthen the guardrails for AI

Beyond discussions about artificial intelligence, other key topics are likely to be the Iran war, an ongoing trade truce and Chinese cars. Source：MarketWatch

来源：https://www.marketwatch.com/story/peptides-could-soon-become-widely-available-in-the-u-s-heres-what-happens-next-ead02287